Iressa

Gefitinib

8.1 High risk

Iressa & Malignant neoplasm progression

28.8%

of users reported Malignant neoplasm progression

89.6%

also reported Severe reaction

69.4%

are women

Most common medical consequences

Severe reaction
89.6%
Death
7.6%
Hospitalization
2.4%
Life-threatening condition
0.3%

Have you experienced any negative side effects from this medication?

Iressa: general information

Most common side effects (49)

Most commonly affected ages

40 - 49 years
2.3%
50 - 59 years
18.1%
60 - 69 years
31.6%
70 - 79 years
28.3%
80 - 89 years
18.9%
90 - 99 years
0.8%